First drug approved for NASH

BfArM speeds up the approval process for clinical trials in Germany

Correct interpretation of key CGM metrics

GLP-1 based drugs: Could Elon Musk’s weight loss weapon help us, too?

Profil's scientific publications in 2023 - an overview

A novel long-acting Amylin analogue for the management of obesity

Free Live Online Seminar: IMP management services for multi and single-center clinical trials in EU

CTR 536/2014: First approvals and our experience with CTIS (Part 3)

Profil World - The clinical diabetes research newsletter - Jun 2023

Corporate Social Responsibility in Clinical Trials